COLL Earnings Collegium Pharmaceutical, Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -0.02 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.40 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 1.73 | 2026-02-26 | 10-K |
| FY 2025 | 2025-09-30 | 0.84 | 2026-02-26 | 10-K |
| Q2 2026 | 2025-06-30 | 0.44 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.07 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 1.86 | 2026-02-26 | 10-K |
| FY 2025 | 2024-09-30 | 0.27 | 2026-02-26 | 10-K |
| FY 2025 | 2024-06-30 | 0.52 | 2026-02-26 | 10-K |
| FY 2025 | 2024-03-31 | 0.71 | 2026-02-26 | 10-K |
| FY 2025 | 2023-12-31 | 1.29 | 2026-02-26 | 10-K |
| FY 2024 | 2023-09-30 | 0.53 | 2025-02-27 | 10-K |
| FY 2024 | 2023-06-30 | 0.34 | 2025-02-27 | 10-K |
| FY 2024 | 2023-03-31 | -0.51 | 2025-02-27 | 10-K |
| FY 2024 | 2022-12-31 | -0.74 | 2025-02-27 | 10-K |
| FY 2023 | 2022-09-30 | 0.01 | 2024-02-22 | 10-K |
| FY 2023 | 2022-06-30 | -0.15 | 2024-02-22 | 10-K |
| FY 2023 | 2022-03-31 | -0.39 | 2024-02-22 | 10-K |
| FY 2023 | 2021-12-31 | 1.86 | 2024-02-22 | 10-K |
| FY 2022 | 2021-09-30 | 0.22 | 2023-02-23 | 10-K |
| FY 2022 | 2021-06-30 | 1.79 | 2023-02-23 | 10-K |
| FY 2022 | 2021-03-31 | 0.41 | 2023-02-23 | 10-K |
| FY 2022 | 2020-12-31 | 0.76 | 2023-02-23 | 10-K |
| FY 2021 | 2020-09-30 | 0.32 | 2022-02-24 | 10-K |
| FY 2021 | 2020-06-30 | 0.23 | 2022-02-24 | 10-K |
| FY 2021 | 2020-03-31 | 0.01 | 2022-02-24 | 10-K |
| FY 2021 | 2019-12-31 | -0.68 | 2022-02-24 | 10-K |
| Q3 2020 | 2019-09-30 | -0.62 | 2020-11-05 | 10-Q |
| Q2 2020 | 2019-06-30 | -0.43 | 2020-08-05 | 10-Q |
| Q1 2020 | 2019-03-31 | -0.29 | 2020-05-07 | 10-Q |
| FY 2020 | 2018-12-31 | -1.19 | 2021-02-25 | 10-K |
| FY 2019 | 2018-09-30 | -0.50 | 2020-02-27 | 10-K |
| FY 2019 | 2018-06-30 | -0.40 | 2020-02-27 | 10-K |
| FY 2019 | 2018-03-31 | -0.57 | 2020-02-27 | 10-K |
| Q1 2016 | 2016-03-31 | -0.68 | 2016-05-11 | 10-Q |
| FY 2016 | 2015-12-31 | -0.46 | 2017-03-10 | 10-K |
| FY 2016 | 2015-09-30 | -0.46 | 2017-03-10 | 10-K |
| FY 2016 | 2015-06-30 | -0.45 | 2017-03-10 | 10-K |
| FY 2016 | 2015-03-31 | -0.65 | 2017-03-10 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.